Montreal Cognitive Assessment Orientation TestNCIt concept

https://www.pedia-univ.fr/deuxieme-cycle/referentiel/neurologie/lenfant-handicape-orientation-prise-charge
2024
France
educational course
Disabled
Child Individual
Orientation
Montreal Cognitive Assessment Orientation Test
Direction
Referring
child, nos
orientation, nos
patient care management
Children with Disabilities
orientation
CDISC ADAS-Cog - Orientation Summary Score
Child Relation
Charge
Disabled Population
handicap
Referral

---
https://publications.msss.gouv.qc.ca/msss/document-003760/
2024
false
false
false
Canada
public health guidelines
orientation, nos
prisons
orientation
Referral
medical laboratory science
Healthcare Facility
Scriber Device
medical assistance
medical device, nos
Montreal Cognitive Assessment Orientation Test
CDISC ADAS-Cog - Orientation Summary Score
equipment and supplies
recreation
Assistive Device
Direction
Orientation
Apparatus
Referring

---
https://publications.msss.gouv.qc.ca/msss/document-003757/
2024
Canada
guideline
Kit Dosage Form
Human Cells, Tissues, and Cellular and Tissue-Based Products Packing
CDISC ADAS-Cog - Orientation Summary Score
Montreal Cognitive Assessment Orientation Test
Drug Kit
Direction
transposition of great vessels
Mast/Stem Cell Growth Factor Receptor Kit
Referral
Thoracic Gas Volume
Check
Orientation
Overall
Verification
orientation
Certification
Referring
auditor
certification
Package
Package Dosing Unit
orientation, nos
KIT wt Allele
Oncogene KIT
Kit Dosing Unit

---
https://iris.who.int/bitstream/handle/10665/376333/WHO-WHE-EPP-2024.3-fre.pdf
2024
Switzerland
public health guidelines
Montreal Cognitive Assessment Orientation Test
Biological Son
Biological or Textual Reference to Actual Test or Parameter
CDISC ADAS-Cog - Orientation Summary Score
orientation
biology
Clinical Trial Notification of Safety or Other Trial Information Documentation
Referral
Biological
Biological Challenge Agent
SARS Coronavirus
laboratory reporting, nos
Biology
biology
Institutional Review Board Independent Ethics Committee Notification of Safety Information Documentation
SARS-CoV-2
safety
containment of biohazards
Direction
Orientation
Referring
Safety Report
laboratories
COVID-19 Infection
Biological Agent
orientation, nos
research report
COVID-19

---
https://iris.who.int/handle/10665/375979
2024
Switzerland
public health guidelines
Point-of-Care Testing
epidemics
orientation, nos
Laboratory Test Time
laboratory test, nos
no diagnosis
Application Context
orientation
Epidemic Disorder
CDISC Provisional Standard
Referring
laboratories
diphtheria
disease outbreaks
diphtheria, nos
Referral
Interim
Diphtheria
Date of Diagnosis
Orientation
Diagnosis Study
Montreal Cognitive Assessment Orientation Test
Laboratory Procedure
Direction
Diagnosis Code
diagnosis
CDISC ADAS-Cog - Orientation Summary Score

---
https://publications.msss.gouv.qc.ca/msss/document-003778/
2024
Canada
technical report
Organization Name
CDISC ADAS-Cog - Orientation Summary Score
Orientation
emergencies
paper
orientation, nos
Referral
Montreal Cognitive Assessment Orientation Test
Direction
organizations
Emergency Room
emergency medical services
Reference Document
orientation
Organization
social planning
Other Agency or Organization
Referring
Plan
organizers, embryonic
organization

---
https://publications.msss.gouv.qc.ca/msss/document-003659/
2023
Canada
scientific and technical information
Scheduled
Referral
Program
orientation, nos
Orientation
Referring
medical oncology
orientation
Montreal Cognitive Assessment Orientation Test
Schedule
Direction
CDISC ADAS-Cog - Orientation Summary Score

---
https://publications.msss.gouv.qc.ca/msss/document-003655/
2023
Canada
handbooks
Case Management
Direction
Contact Person
Communication Contact
COVID-19
Respiratory System Finding
Respiratory System
Inclusive
prisons
CDISC ADAS-Cog - Orientation Summary Score
infectious diseases
Referring
Montreal Cognitive Assessment Orientation Test
orientation
Include
Orientation
COVID-19 Infection
Physical Contact
disease
communicable diseases
infectious disease, nos
Referral
case management
disease of respiratory system, nos
orientation, nos

---
https://iris.who.int/bitstream/handle/10665/373076/WHO-2019-nCoV-Surveillance_Guidance-Addendum-2023.1-fre.pdf
2023
Switzerland
technical report
orientation, nos
Referring
paper
repetitive strain injury, nos
Safety Tracking Document
Referral
dataset
Application Context
COVID-19
International Health Regulations
Data Monitoring
Montreal Cognitive Assessment Orientation Test
CDISC ADAS-Cog - Orientation Summary Score
CDISC Provisional Standard
public health surveillance
registries
Direction
Radiosensitivity Index
orientation
Update
Public Health
Software Maintenance
COVID-19 Infection
Orientation
Restriction Spectrum Imaging
Interim
Notification

---
https://iris.who.int/handle/10665/371307
2023
Switzerland
technical report
COVID-19 Vaccine
preventive immunization/medication
CDISC ADAS-Cog - Orientation Summary Score
vaccination
orientation
vaccination
Revision
Orientation
COVID-19
Montreal Cognitive Assessment Orientation Test
Direction
COVID-19 Vaccines
Referring
May
Vaccinated for COVID-19
vaccination, nos
orientation, nos
Referral

---
https://iris.who.int/handle/10665/369131
2023
Switzerland
technical report
biology
Biological Son
risk
Lifetime Risk
attenuated by
Referral
Biology
CDISC SDTM Environmental Setting Terminology
hazardous substances
CDISC ADAS-Cog - Orientation Summary Score
Biological Challenge Agent
biological science disciplines
Biotechnology
Biological
Usage
Research
orientation
Referring
research
orientation, nos
Direction
Montreal Cognitive Assessment Orientation Test
biology
Biological Agent
science
Responsible Person
life
Mitigate
Biological or Textual Reference to Actual Test or Parameter
Orientation
Search

---
https://dumas.ccsd.cnrs.fr/dumas-04116741
2023
France
dissertations, academic
Tumor Progression Absent After Initial Treatment
Preoperative IV Sedation was Not Administered
ROS1 Rearrangement Analysis Was Not Performed
Criterion
ALK Rearrangement Analysis Was Not Performed
Has No Sibling
retrospective studies
Retrospective Study
Preoperative IV Antacids were not Administered
10q23/PTEN Locus Deletion Analysis Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
EGFR Amplification Analysis Was Not Performed
Regional Anesthesia was not Administered
Regular Smokeless Tobacco Use for Six Weeks or More Negative
1p/19q Deletion Analysis Was Not Performed
Another Form of Birth Control was not Used
CDISC ADAS-Cog - Orientation Summary Score
Complex Endometrial Hyperplasia
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Patient was Not Previously Evaluated for Current Chief Complaint
No Known History of Illicit Drug Use
Adjuvant Post-operative Radiation Therapy Was Not Administered
RET Rearrangement Analysis Was Not Performed
EGFR Mutation Analysis Was Not Performed
TP53 Mutation Analysis Was Not Performed
EGFR Gene Amplification Negative
orientation
PTEN Mutation Analysis Was Not Performed
stress, nos
BRAF Mutation Analysis Was Not Performed
Stress
Lymph Node Dissection Was Not Performed
Other Preoperative IV Medications were not Administered
Radiation Therapy Not Received
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Immunohistochemistry Was Not Performed
Additional Surgery for New Tumor Event Absent
No Response to Intervention for Kawasaki Disease
Negation
absence of stress
Nitric Oxide
IDH Family Wildtype
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
IDH Family Mutation Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Patient
NRAS Mutation Analysis Was Not Performed
Montreal Cognitive Assessment Orientation Test
Preoperative IV Antiemetics were not Administered
review literature as topic
Chief Complaint was Not Witnessed
Systematic Review
Hypertension Absent
Neither
patients
ATRX Gene Mutation Negative
Preoperative IV Opiates were not Administered
New Tumor Event After Initial Treatment Absent
ATRX Mutation Analysis Was Not Performed
injury, nos
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Reviewing
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
ERBB2 Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Routine Cytogenetics Were not Completed
First Degree Family History Cancer Negative
Chemotherapy Not Received
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
MGMT Promoter Methylation Testing Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Patient was not Postmenopausal with no Prior Oophorectomy
PTEN Gene Mutation Negative
No History of Gestational Complication
Additional Molecular Studies Were Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Not Lost to Follow-Up
NF1 Mutation Analysis Was Not Performed
Documentation Absent
Use of Smokeless Tobacco at Time of Diagnosis Negative
stress disorders, post-traumatic
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Intervention Not Given for Kawasaki Disease
History of Colorectal Cancer Negative
Injury
NON Mouse
Adjuvant Post-operative Chemotherapy Was Not Administered
No History of Rheumatic Fever
Norway
Neither Case or Control Status
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Congenital Heart Disease
Nitric Oxide Measurement
Orientation
classification
Minor Criteria for Rheumatic Heart Disease Not Present
Direction
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Therapeutic Ionizing Radiation to Head History Absent
No History of Neonatal Complication
Adjuvant Post-operative Immunological Therapy Was Not Administered
TP53 Gene Mutation Negative
Chemical/Occupational Exposure Absent
New Disease is not Multifocal
disturbance of orientation, nos
Caffeine Not Routinely Consumed
Cancer History Absent
No Known History of Alcohol Use
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Adjuvant I-131 Therapy Negative
History of Medical Treatment Absent
MET Mutation Analysis Was Not Performed
Radiation History Negative
KRAS Mutation Analysis Was Not Performed
patient referral, nos
KIT Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
Chief Complaint Not Caused by Trauma
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Unemployed
Family History of Stomach Cancer Absent
Medication Not Taken
Referral
Paraneoplastic Syndrome is Not Present
No History of Non-Cardiac Surgery
PDGFRA Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
IV Anesthesia was not Administered
No History of Kawasaki Disease
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Referring
Local Anesthesia Agents were not Administered
No History of Myopathy
Additional Surgery for New Metastatic Tumor Event Was Not Performed
First Degree Family History of Primary Brain Tumor Negative
Tumor Reoccurrence Absent After Initial Treatment
Any Metastatic Diagnosis Absent
Complex Karyotype
Physician Diagnosed Diabetes Absent

---
https://iris.who.int/bitstream/handle/10665/375236/WHO-2019-nCoV-IPC-guideline-summary-2023.4-fre.pdf
2023
Switzerland
public health guidelines
Direction
CDISC ADAS-Cog - Orientation Summary Score
wrestling
infectious diseases
Application Context
coronavirus, nos
Abstract
Curriculum Vitae
Infectious Disease Pathway
Montreal Cognitive Assessment Orientation Test
Coronavirus
Abstracting
orientation, nos
coronavirus
communicable diseases
infectious disease, nos
Coronaviridae Measurement
orientation
anti-infective agents
disease
Referral
Restart
COVID-19 Infection
Orientation
Referring
COVID-19

---